Pharming Total Assets from 2010 to 2025

PHAR Stock

USD 8.84 0.09 1.01%

Pharming Group Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to drop to about 202.9 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2009-12-31

Previous Quarter

415.9 M

Current Value

425.5 M

Quarterly Volatility

155.6 M

Credit Downgrade

Yuan Drop

Covid

Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 16.3 M, Interest Expense of 6.4 M or Selling And Marketing Expenses of 120.4 M, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 3.92. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.

Check out the analysis of Pharming Group Correlation against competitors.

Latest Pharming Group's Total Assets Growth Pattern

Below is the plot of the Total Assets of Pharming Group NV over the last few years. Total assets refers to the total amount of Pharming Group assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pharming Group NV books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Pharming Group's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 386.88 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Pharming Total Assets Regression Statistics

	Arithmetic Mean	212,354,139
	Geometric Mean	140,565,544
	Coefficient Of Variation	76.40
	Mean Deviation	138,268,808
	Median	202,890,909
	Standard Deviation	162,240,317
	Sample Variance	26321.9T
	Range	440.6M
	R-Value	0.86
	Mean Square Error	7554T
	R-Squared	0.73
	Significance	0.000024
	Slope	29,158,428
	Total Sum of Squares	394828.8T

Pharming Total Assets History

	2025	202.9 M
	2024	386.9 M
	2023	462.9 M
	2022	425.8 M
	2021	396.9 M
	2020	419.1 M
	2019	255.6 M

Other Fundumenentals of Pharming Group NV

Intangibles To Total Assets

Pharming Group Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Good Will	Net Tangible Assets	Long Term Debt	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Capital Stock	Long Term Investments
Total Assets		0.89	0.22	0.23	0.23	0.32	0.67	0.44	0.96	0.92	0.12	0.88	-0.37	-0.28	0.84	0.71	-0.63	0.89	-0.58	0.73	0.72	0.59	0.72
Total Stockholder Equity	0.89		0.14	0.31	0.45	0.61	0.84	0.64	0.78	0.98	-0.06	0.71	-0.28	-0.19	0.98	0.75	-0.77	0.94	-0.7	0.91	0.92	0.78	0.83
Current Deferred Revenue	0.22	0.14		-0.34	-0.16	-0.13	0.03	-0.24	0.22	0.08	0.39	0.39	-0.11	-0.11	0.05	-0.23	0.5	0.0	0.26	-0.16	-0.15	-0.02	-0.29
Net Debt	0.23	0.31	-0.34		0.09	0.55	0.66	0.85	0.26	0.36	0.07	0.17	-0.12	-0.13	0.37	0.31	-0.46	0.36	-0.28	0.46	0.48	0.45	0.51
Retained Earnings	0.23	0.45	-0.16	0.09		0.22	0.26	0.35	0.0	0.33	-0.43	0.0	0.43	0.54	0.42	0.47	-0.43	0.45	-0.48	0.47	0.48	0.36	0.49
Accounts Payable	0.32	0.61	-0.13	0.55	0.22		0.86	0.74	0.25	0.57	-0.08	0.22	-0.17	-0.12	0.68	0.49	-0.57	0.58	-0.49	0.74	0.74	0.89	0.65
Net Receivables	0.67	0.84	0.03	0.66	0.26	0.86		0.85	0.61	0.82	0.15	0.56	-0.31	-0.24	0.88	0.54	-0.7	0.78	-0.49	0.83	0.87	0.84	0.78
Short Term Investments	0.44	0.64	-0.24	0.85	0.35	0.74	0.85		0.36	0.65	-0.17	0.2	-0.13	-0.09	0.7	0.58	-0.68	0.67	-0.54	0.77	0.78	0.73	0.76
Total Liab	0.96	0.78	0.22	0.26	0.0	0.25	0.61	0.36		0.86	0.26	0.94	-0.44	-0.37	0.73	0.59	-0.53	0.76	-0.48	0.62	0.59	0.47	0.58
Total Current Assets	0.92	0.98	0.08	0.36	0.33	0.57	0.82	0.65	0.86		-0.06	0.76	-0.36	-0.27	0.96	0.79	-0.77	0.94	-0.74	0.91	0.89	0.76	0.82
Short Term Debt	0.12	-0.06	0.39	0.07	-0.43	-0.08	0.15	-0.17	0.26	-0.06		0.45	-0.26	-0.19	-0.08	-0.55	0.22	-0.2	0.66	-0.33	-0.21	-0.24	-0.26
Intangible Assets	0.88	0.71	0.39	0.17	0.0	0.22	0.56	0.2	0.94	0.76	0.45		-0.39	-0.29	0.64	0.4	-0.37	0.63	-0.31	0.48	0.48	0.38	0.43
Common Stock	-0.37	-0.28	-0.11	-0.12	0.43	-0.17	-0.31	-0.13	-0.44	-0.36	-0.26	-0.39		0.88	-0.28	-0.15	0.21	-0.25	0.12	-0.22	-0.24	-0.19	-0.21
Good Will	-0.28	-0.19	-0.11	-0.13	0.54	-0.12	-0.24	-0.09	-0.37	-0.27	-0.19	-0.29	0.88		-0.23	-0.13	0.16	-0.21	0.1	-0.18	-0.19	-0.16	-0.17
Net Tangible Assets	0.84	0.98	0.05	0.37	0.42	0.68	0.88	0.7	0.73	0.96	-0.08	0.64	-0.28	-0.23		0.76	-0.82	0.95	-0.71	0.95	0.96	0.82	0.88
Long Term Debt	0.71	0.75	-0.23	0.31	0.47	0.49	0.54	0.58	0.59	0.79	-0.55	0.4	-0.15	-0.13	0.76		-0.73	0.88	-0.95	0.88	0.79	0.78	0.85
Deferred Long Term Liab	-0.63	-0.77	0.5	-0.46	-0.43	-0.57	-0.7	-0.68	-0.53	-0.77	0.22	-0.37	0.21	0.16	-0.82	-0.73		-0.8	0.69	-0.86	-0.89	-0.64	-0.91
Net Invested Capital	0.89	0.94	0.0	0.36	0.45	0.58	0.78	0.67	0.76	0.94	-0.2	0.63	-0.25	-0.21	0.95	0.88	-0.8		-0.78	0.93	0.92	0.83	0.93
Short Long Term Debt	-0.58	-0.7	0.26	-0.28	-0.48	-0.49	-0.49	-0.54	-0.48	-0.74	0.66	-0.31	0.12	0.1	-0.71	-0.95	0.69	-0.78		-0.87	-0.76	-0.72	-0.75
Net Working Capital	0.73	0.91	-0.16	0.46	0.47	0.74	0.83	0.77	0.62	0.91	-0.33	0.48	-0.22	-0.18	0.95	0.88	-0.86	0.93	-0.87		0.97	0.88	0.92
Property Plant Equipment	0.72	0.92	-0.15	0.48	0.48	0.74	0.87	0.78	0.59	0.89	-0.21	0.48	-0.24	-0.19	0.96	0.79	-0.89	0.92	-0.76	0.97		0.84	0.94
Capital Stock	0.59	0.78	-0.02	0.45	0.36	0.89	0.84	0.73	0.47	0.76	-0.24	0.38	-0.19	-0.16	0.82	0.78	-0.64	0.83	-0.72	0.88	0.84		0.81
Long Term Investments	0.72	0.83	-0.29	0.51	0.49	0.65	0.78	0.76	0.58	0.82	-0.26	0.43	-0.21	-0.17	0.88	0.85	-0.91	0.93	-0.75	0.92	0.94	0.81

Click cells to compare fundamentals

About Pharming Group Financial Statements

Pharming Group shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. The changes in Pharming Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharming Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	386.9 M	202.9 M
Intangibles To Total Assets	0.18	0.22

Additional Tools for Pharming Stock Analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC